Literature DB >> 8354184

Mechanisms of multistep carcinogenesis and carcinogen risk assessment.

J C Barrett1.   

Abstract

Many different types of chemical exposures can increase the incidence of tumors in animals and humans, but usually a long period of time is required before the carcinogenic risk of an exposure is manifested. Both of these observations can be explained by a multistep/multigene model of carcinogenesis. In this model, a normal cell evolves into a cancer cell as the result of heritable changes in multiple, independent genes. The two-stage model of initiation and promotion for chemical carcinogenesis has provided a paradigm by which chemicals can act by qualitatively different mechanisms, but the process of carcinogenesis is now recognized as more complex than simply initiation and promotion. Even a three-stage model of initiation, promotion, and progression, which can be operationally defined, is not adequate to describe the carcinogenic process. The number of genes altered in a cancer cell compared to a normal cell is not known; recent evidence suggests that 3-10 genetic events are involved in common adult malignancies in humans. Two distinct classes of genes, protooncogenes and tumor-suppressor genes, are involved in the cancer process. Multiple oncogenes may be activated in a tumor, while multiple tumor-suppressor genes may be inactivated. Identification of the genes involved in carcinogenesis and elucidation of the mechanisms of their activation or inactivation allows a better understanding of how chemical carcinogens influence the process of neoplastic evolution. The findings of multiple genetic changes (including point mutations, chromosomal translocations, deletions, gene amplification, and numerical chromosome changes) in activated protooncogenes and inactivated tumor-suppressor genes provide experimental support for Boveri's somatic mutation theory of carcinogenesis. In addition to mutagenic mechanisms, chemicals may heritably alter cells by epigenetic mechanisms and enhance the clonal expansion of altered cells. Most chemical carcinogens operate via a combination of mechanisms, and even their primary mechanism of action may vary depending on the target tissues. The classification of chemicals by mechanism of action or by nongenotoxic or genotoxic activity has certain inherent difficulties because no classification of chemicals is exhaustive or definitive.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354184      PMCID: PMC1519586          DOI: 10.1289/ehp.931009

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  75 in total

1.  Induction of cellular senescence in immortalized cells by human chromosome 1.

Authors:  O Sugawara; M Oshimura; M Koi; L A Annab; J C Barrett
Journal:  Science       Date:  1990-02-09       Impact factor: 47.728

Review 2.  Endogenous carcinogenesis: molecular oncology into the twenty-first century--presidential address.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

Review 3.  Genetic and cellular basis of multistep carcinogenesis.

Authors:  J A Boyd; J C Barrett
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

4.  Allelotype of colorectal carcinomas.

Authors:  B Vogelstein; E R Fearon; S E Kern; S R Hamilton; A C Preisinger; Y Nakamura; R White
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

5.  Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens.

Authors:  G M Ledda-Columbano; A Columbano; M Curto; M G Ennas; P Coni; D S Sarma; P Pani
Journal:  Carcinogenesis       Date:  1989-05       Impact factor: 4.944

Review 6.  Particulate-state carcinogenesis: a survey of recent studies on the mechanisms of action of fibres.

Authors:  M C Jaurand
Journal:  IARC Sci Publ       Date:  1989

Review 7.  Mutations in human breast cancer: an overview.

Authors:  R Callahan; G Campbell
Journal:  J Natl Cancer Inst       Date:  1989-12-06       Impact factor: 13.506

Review 8.  Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice.

Authors:  J E Huff; J K Haseman; D M DeMarini; S Eustis; R R Maronpot; A C Peters; R L Persing; C E Chrisp; A C Jacobs
Journal:  Environ Health Perspect       Date:  1989-07       Impact factor: 9.031

Review 9.  Evidence supporting a role for active oxygen species in asbestos-induced toxicity and lung disease.

Authors:  B T Mossman; J P Marsh
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

Review 10.  Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers.

Authors:  J C Barrett; P W Lamb; R W Wiseman
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

View more
  47 in total

1.  Cancer risks after radiation exposure in middle age.

Authors:  Igor Shuryak; Rainer K Sachs; David J Brenner
Journal:  J Natl Cancer Inst       Date:  2010-10-25       Impact factor: 13.506

2.  Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinoma.

Authors:  Heike Loeser; Dirk Waldschmidt; Fabian Kuetting; Simon Schallenberg; Thomas Zander; Elfriede Bollschweiler; Arnulf Hoelscher; Katharina Weckermann; Patrick Plum; Hakan Alakus; Reinhard Buettner; Alexander Quaas
Journal:  Mol Clin Oncol       Date:  2017-06-08

3.  Expression of Gab1 lacking the pleckstrin homology domain is associated with neoplastic progression.

Authors:  H Kameda; J I Risinger; B B Han; S J Baek; J C Barrett; T Abe; T Takeuchi; W C Glasgow; T E Eling
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

4.  Carcinogens induce reversion of the mouse pink-eyed unstable mutation.

Authors:  R H Schiestl; J Aubrecht; F Khogali; N Carls
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Metastasis to the F344 Rat Pancreas from Lung Cancer Induced by 4-(Methylnitrosamino)- 1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)- 1-butanol, Constituents of Tobacco Products.

Authors:  Ramesh C Kovi; Charles S Johnson; Silvia Balbo; Stephen S Hecht; M Gerard O'Sullivan
Journal:  Toxicol Pathol       Date:  2018-02-01       Impact factor: 1.902

6.  Carcinogenic Potential of High Aspect Ratio Carbon Nanomaterials.

Authors:  Sudjit Luanpitpong; Liying Wang; Donna C Davidson; Heimo Riedel; Yon Rojanasakul
Journal:  Environ Sci Nano       Date:  2016-04-06

7.  Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny.

Authors:  Rina Ashkenazi; Sara N Gentry; Trachette L Jackson
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

8.  Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc.

Authors:  Li Sheng-Fowler; Fang Cai; Haiqing Fu; Yong Zhu; Brian Orrison; Gideon Foseh; Don G Blair; Stephen H Hughes; John M Coffin; Andrew M Lewis; Keith Peden
Journal:  Int J Biol Sci       Date:  2010-03-29       Impact factor: 6.580

9.  (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer.

Authors:  J C Zenklusen; I Bièche; R Lidereau; C J Conti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  Mechanistic study on lung cancer mortality after radon exposure in the Wismut cohort supports important role of clonal expansion in lung carcinogenesis.

Authors:  I Zaballa; M Eidemüller
Journal:  Radiat Environ Biophys       Date:  2016-06-22       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.